Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty (Q80442873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

S Yamasaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

K Masuhara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

K Yamaguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

T Nakai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

T Fuji

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Y Seino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

15 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1009-1015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554581%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-007-0339-7

31 December 2019

exact match

0 references

cites work

Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem

1 reference

12 December 2020

Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa

1 reference

12 December 2020

Long-term results using the anatomic medullary locking hip prosthesis.

1 reference

12 December 2020

"Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening

1 reference

12 December 2020

Longitudinal evaluation of time related bone remodeling after cementless total hip arthroplasty

1 reference

12 December 2020

The effect of alendronate (Fosamax) and implant surface on bone integration and remodeling in a canine model

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

[Improved osseointegration and periprosthetic bone volume around cementless metal implants under bisphosphonate treatment]

1 reference

12 December 2020

Madreporic, polarized total arthroplasties of the hip. Apropos of 2688 cases

1 reference

12 December 2020

Effects of discontinuation as well as intervention of cyclic therapy with etidronate on bone remodeling after cementless total hip arthroplasty

1 reference

12 December 2020

An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae

1 reference

12 December 2020

Results of the Harris-Galante cementless hip prosthesis

1 reference

12 December 2020

Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study.

1 reference

12 December 2020

Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial.

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Evaluation of periprosthetic bone-remodeling after cementless total hip arthroplasty. The influence of the extent of porous coating

1 reference

12 December 2020

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

12 December 2020

Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty

1 reference

12 December 2020

Cementless total hip arthroplasty using the anatomic medullary locking stem. Results using a survivorship analysis

1 reference

12 December 2020

Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study.

1 reference

12 December 2020

Effect of alendronate on fracture healing and bone remodeling in dogs

1 reference

12 December 2020

Bone density changes with once weekly risedronate in postmenopausal women

1 reference

12 December 2020

Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty

1 reference

12 December 2020

Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty

1 reference

12 December 2020

Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease

1 reference

12 December 2020

Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study

1 reference

12 December 2020

The influence of stem size and extent of porous coating on femoral bone resorption after primary cementless hip arthroplasty

1 reference

12 December 2020

Total hip replacement with cemented, uncemented, and hybrid prostheses. A comparison of clinical and radiographic results at two to four years.

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

The porous-coated anatomic total hip prosthesis, inserted without cement. A prospective study with a minimum of ten years of follow-up

1 reference

12 December 2020

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1 reference

12 December 2020

Efficacy and acceptability of risedronate 5 mg daily compared with 35 mg once weekly for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020